Assignee
CERENO SCIENT AB
SE·5 granted patents·7 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
12 records- 0173US12245999B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2022·Granted Mar 11, 2025·0 cites·17 claims
- 0268US2023094176A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 0367US12023311B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2022·Granted Jul 2, 2024·0 cites·22 claims
- 0466US2025241880A1Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2025·Application pending·0 cites
- 0565US2023364089A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2023·Application pending·0 cites
- 0664US11400064B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2018·Granted Aug 2, 2022·0 cites·9 claims
- 0762US2025066282A1Novel analogs of valproic acid and methods of medical treatment using the sameCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 0859US2021060014A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2020·Application pending·0 cites
- 0955US10111845B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2015·Granted Oct 30, 2018·0 cites·24 claims
- 1052US11395808B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2017·Granted Jul 26, 2022·0 cites·18 claims
- 1147US2020179381A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2017·Application pending·0 cites
- 1245US2017020874A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →